Global Dronabinol (CAS 1972-08-3) Market to Grow at a CAGR of 191.9% during 2021-2026

The global Dronabinol (CAS 1972-08-3) market was valued at US$ 150.3 million in 2019 and is expected to reach US$ 191.9 million by the end of 2026, growing at a CAGR of 4.5% during 2021-2026.

Dronabinol is a form of delta-9-tetrahydrocannabinol (Δ⁹-THC), the primary psychoactive component of cannabis (marijuana). THC demonstrates its effects through weak partial agonist activity at Cannabinoid-1 (CB1R) and Cannabinoid-2 (CB2R) receptors, which results in the well-known effects of smoking cannabis such as increased appetite, reduced pain, and changes in emotional and cognitive processes. Due to its evidence as an appetite stimulant and an anti-nauseant, Dronabinol is approved for use in anorexia associated with weight loss in patients with AIDS and for the treatment of nausea and vomiting associated with cancer chemotherapy in patients who have failed to respond adequately to conventional antiemetic treatments.

In 2019, the global Dronabinol (CAS 1972-08-3) market is led by North America. Europe is the second-largest region-wise market.

Noramco, Canopy Growth, THC Pharm, Echo Pharmaceuticals and Aphios Corporation are the major players in the world, top five manufactures occupied nearly 52% of the revenue market share in 2019.

In terms of types, Purity 99% occupied the largest sales share of about 72% in 2019.

Find more details about this report at:

(Impact of COVID-19 is covered in report)

The Dronabinol (CAS 1972-08-3) market research report includes specific segments by region (country), by manufacturers, by Type and by Application. Each type provides information about the production during the forecast period of 2016 to 2027. By Application segment also provides consumption during the forecast period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

Key Companies included in Dronabinol (CAS 1972-08-3) market report are Canopy Growth, Noramco, KinetoChem, Entourage Phytolab, THC Pharm, Echo Pharmaceuticals, BOL Pharma, Aphios Corporation, Benuvia Manufacturi  and more in terms of company basic information, product portfolio, Production, Revenue, Price, Gross Margin (2016-2021) & Recent Developments/Updates.

Table of Content:

1 Dronabinol (CAS 1972-08-3) Market Overview

– Product Overview and Scope, Market Size Growth Rate Analysis by Type, Consumption Comparison by Application, Growth Prospects)

2 Dronabinol (CAS 1972-08-3) Market Competition by Manufacturers

– Sales & Revenue Market Share, Average Price, Manufacturing Sites, Area Served, Product Type, Competitive Situation and Trends

3 Dronabinol (CAS 1972-08-3) Retrospective Market Scenario by Region

– Global Market Scenario in Sales & Revenue by Region: 2016-2021

– North America (United States, Canada)

– Europe (Germany, France, U.K., Italy, Russia)

– Asia Pacific (China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia)

– Latin America (Mexico, Brazil, Argentina, Colombia)

– Middle East and Africa (Turkey, Saudi Arabia, UAE)

4 Global Dronabinol (CAS 1972-08-3) Historic Market Analysis by Type

– Global Sales & Revenue Market Share by Type (2016-2021), Global Price by Type (2016-2021)

5 Global Dronabinol (CAS 1972-08-3) Historic Market Analysis by Application

– Global Sales & Revenue Market Share by Application (2016-2021), Global Kits Price by Application (2016-2021)

6 Key Companies Profiled

– Corporation Information, Business Overview, Kits Sales, Revenue, Gross Margin (2016-2021), Product Portfolio

7 Dronabinol (CAS 1972-08-3) Manufacturing Cost Analysis

– Key Raw Materials, Suppliers, Manufacturing Cost Structure, Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers

9 Dronabinol (CAS 1972-08-3) Market Dynamics

– Trends, Drivers, Challenges, Restraints

10 Global Market Forecast

– Global Forecasted Sales & Revenue by Type (2022-2027), Global Forecasted Sales & Revenue by Application (2022-2027), Global Forecasted Sales & Revenue by Region (2022-2027)

11 Research Finding and Conclusion

12 Methodology and Data Source